Parotid hemangiomas: a review

Authors

DOI:

https://doi.org/10.29176/30284163.2004

Keywords:

Diagnosis, Parotid hemangiomas, Propraranolol, Treatment

Abstract

Infantile hemangiomas (IH) are the most common tumors in pediatrics, most of them do not require treatment and regress spontaneously as part of their natural evolution. Its first-line treatment is based on the use of beta-blockers (propranolol) and is performed in those who have a higher risk of complications such as ulceration, bleeding or growth that leads to disfigurement or compression.

Within infantile hemangiomas, those located in the parotid occupy a special chapter due to their deep location, which together with their expansive growth can lead to significant aesthetic deformities, as well as functional alteration of adjacent structures.

If we focus on tumors of the parotid gland in children, IH occupies first place in frequency (estimated at 50%)(1), and it has been reported that IH in this location have a different evolution, with a phase longer proliferative, as well as slower involution and response to therapy with propranolol, sometimes requiring more interventional options such as sclerotherapy (2).

The objective of this work is to characterize the results obtained in the study of infantile parotid hemangiomas, both at the diagnostic and therapeutic levels and follow-up, based on reviews and case series obtained by searching using the Pubmed database and the Cochrane Library.

Author Biographies

Florencia García Santana, Unidad Académica de Dermatología, Hospital de Clínicas, Uruguay

Residente de Dermatología, Unidad Académica de Dermatología, Hospital de Clínicas.

Andrés García-Bayce, Centro Hospitalario Pereira Rossell, Uruguay

Profesor agregado de Imagenología Pediátrica, Universidad de la República Oriental del Uruguay. Director, Clínica de Imagenología Pediátrica, Centro Hospitalario Pereira Rossell.

Mariela Álvarez, Centro Hospitalario Pereira Rossell, Uruguay

Dermatóloga. Directora, Unidad de Dermatología Pediátrica, Centro Hospitalario Pereira Rossell.

María Agustina Acosta, Centro Hospitalario Pereira Rossell, Uruguay

Dermatóloga. Profesora adjunta, Unidad Académica de Dermatología, Orientación Dermatología Ppediátrica. Centro Hospitalario Pereira Rossell.

References

Li G, Xu DP, Sun HL, Cheng C, Liu ZM, Xi SL, et al. Oral Propranolol for Parotid Infantile Hemangiomas. J Craniofac Surg. 2015;26(2):438-40. https://doi.org/10.1097/SCS.0000000000001335

Harris J, Phillips JD. Evaluating the Clinical Outcomes of Parotid Hemangiomas in the Pediatric Patient Population. Ear Nose Throat J. 2021;100(5):NP242-NP245. https://doi.org/10.1177/0145561319877760

Novoa M, Baselga E, Beltran S, Giraldo L, Shahbaz A, Pardo‐Hernandez H, et al. Interventions for infantile haemangiomas of the skin. Cochrane Database Syst Rev. 2018;4:CD006545. https://doi.org//10.1002/14651858.CD006545.pub3

Weber FC, Greene AK, Adams DM, Liang MG, Alomari MH, Voss SD, et al. Role of imaging in the diagnosis of parotid infantile hemangiomas. Int J Pediatr Otorhinolaryngol. 2017;102:61-6. https://doi.org/10.1016/j.ijporl.2017.08.035

Wang L, Li S, Gao Q, Lv R, Xu G, Li X, et al. Oral propranolol therapy in parotid hemangiomas: A retrospective comparison with other infantile hemangiomas. Head Neck. 2021;43(5):1553-62. https://doi.org/10.1002/hed.26625

Ma X, Chang M, Ouyang T, Xu D, Xu M, Ke J, et al. Combination of propranolol and sclerotherapy for treatment of infantile parotid hemangiomas. Int J Clin Exp Med. 2015;8(7):10865-74.

Chang L, Jin Y, Lv D, Ying H, Wang T, Qiu Y, et al. Use of propranolol for parotid hemangioma. Head Neck. 2016;38 Suppl 1:E1730-6. https://doi.org/10.1002/hed.24308

Tunc O, Gonuldas B, Kanlikama M. Pediatric parotid gland tumors: Evaluation of 33 cases. Ann Med Res 2021;28(2):366-8. https://doi.org/10.5455/annalsmedres.2020.08.875

Chalard F, Hermann AL, Elmaleh-Bergès M, Ducou le Pointe H. Imaging of parotid anomalies in infants and children. Insights Imaging. 2022;13(1):27. https://doi.org/10.1186/s13244-022-01166-y

Sebaratnam DF, Rodríguez Bandera AL, Wong LF, Wargon O. Infantile hemangioma. Part 2: Management. J Am Acad Dermatol. 2021;85(6):1395-404. https://doi.org/10.1016/j.jaad.2021.08.020.

Xu H, Zheng Y, Chen F, Li X. Diagnosis and characteristics of parotid region lesions in children. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020;34(10):941-4. https://doi.org/10.13201/j.issn.2096-7993.2020.10.017.

Guo L, Wu C, Song D, Wang L, Li J, Sun J, et al. Transcatheter Arterial Sclerosing Embolization for the Treatment of Giant Propranolol-Resistant Infantile Hemangiomas in the Parotid Region. J Vasc Interv Radiol. 2021;32(2):293-8. https://doi.org/10.1016/j.jvir.2020.09.029.

How to Cite

1.
García Santana F, García-Bayce A, Álvarez M, Acosta MA. Parotid hemangiomas: a review. Rev. Hispano-Am. Dermatol. Pediátr. [Internet]. 2025 Feb. 25 [cited 2026 Nov. 21];2(1):25-33. Available from: https://revista.asocolderma.org.co/index.php/dermaped/article/view/2004

Downloads

Download data is not yet available.

Published

2025-02-25

How to Cite

1.
García Santana F, García-Bayce A, Álvarez M, Acosta MA. Parotid hemangiomas: a review. Rev. Hispano-Am. Dermatol. Pediátr. [Internet]. 2025 Feb. 25 [cited 2026 Nov. 21];2(1):25-33. Available from: https://revista.asocolderma.org.co/index.php/dermaped/article/view/2004

Issue

Section

Case report
Scan to share
QR code to open and share this publication